Stock TLIS TALIS BIOMEDICAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Talis Biomedical Corporation

Equities

TLIS

US87424L2079

Delayed Nasdaq
Other stock markets
 10:40:50 26/06/2024 pm IST 		5-day change 1st Jan Change
8.479 USD -3.65% Intraday chart for Talis Biomedical Corporation -2.54% +13.81%
08/05 Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/04 North American Morning Briefing : Stocks Seen -2- DJ

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Talis: Q1 Earnings Snapshot
AQ
Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
North American Morning Briefing : Stocks Seen -2-
DJ
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North American Morning Briefing : Stock Futures Muted; Nvidia Slips in Offhours Trading
DJ
Talis: Q3 Earnings Snapshot
AQ
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
AQ
Talis Biomedical Announces Exploration of Strategic Alternatives
CI
Talis Biomedical Corporation Announces Resignation of Melissa Gilliam from its Board of Directors, as Member of Nominating and Corporate Governance Committee and as Member and Co-Chairperson of Science, Technology and Clinical Affairs Committee
CI
BTIG Adjusts Talis Biomedical's Price Target to $5 From $5.25, Keeps Sell Rating
MT
Talis: Q2 Earnings Snapshot
AQ
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Transcript : Talis Biomedical Corporation, Q2 2023 Earnings Call, Aug 10, 2023
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
AQ
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
AQ
Talis Biomedical Corporation Announces Resignation of Andrew A. Lukowiak as President and Chief Scientific Officer
CI
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
AQ
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu
AQ
Talis Biomedical Corporation Announces New Data Supporting the Development of Its Planned CT/NG/TV and Vinal Infections Panels
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TLIS Stock
  4. News Talis Biomedical Corporation